Sanjay Kulkarni1, Keren Ladin2, Danielle Haakinson1, Erich Greene3, Luhang Li3, Yanhong Deng3. 1. Department of Surgery, Yale School of Medicine, New Haven, Connecticut. 2. Department of Community Medicine and Public Health, Tufts University, Boston, Massachusetts. 3. Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut.
Abstract
Importance: Inactive patients on the kidney transplant wait-list have a higher mortality. The implications of this status change on transplant outcomes between racial/ethnic groups are unknown. Objectives: To determine if activity status changes differ among races/ethnicities and levels of sensitization, and if these differences are associated with transplant probability after implementation of the Kidney Allocation System. Design, Setting, and Participants: A multistate model was constructed from the Organ Procurement and Transplantation Network kidney transplant database (December 4, 2014, to September 8, 2016). The time interval followed Kidney Allocation System implementation and provided at least 1-year follow-up for all patients. The model calculated probabilities between active and inactive status and the following competing risk outcomes: living donor transplant, deceased donor transplant, and death/other. This retrospective cohort study included 42 558 patients on the Organ Procurement and Transplantation Network kidney transplant wait-list following Kidney Allocation System implementation. To rule out time-varying confounding from relisting, analysis was limited to first-time registrants. Owing to variations in listing practices, primary center listing data were used for dually listed patients. Individuals listed for another organ or pancreatic islets were excluded. Analysis began July 2017. Main Outcome and Measures: Probabilities were determined for transitions between active and inactive status and the following outcome states: active to living donor transplant, active to deceased donor transplant, active to death/other, inactive to living donor transplant, inactive to deceased donor transplant, and inactive to death/other. Results: The median (interquartile range) age at listing was 55.0 (18.0-89.0) years, and 26 535 of 42 558 (62.4%) were men. White individuals were 43.3% (n = 18 417) of wait-listed patients, while black and Hispanic individuals made up 27.8% (n = 11 837) and 19.5% (n = 8296), respectively. Patients in the calculated plasma reactive antibody categories of 0% or 1% to 79% showed no statistically significant difference in transplant probability among races/ethnicities. White individuals had an advantage in transplant probability over black individuals in calculated plasma reactive antibody categories of 80% to 89% (hazard ratio [HR], 1.8 [95% CI, 1.4-2.2]) and 90% or higher (HR, 2.4 [95% CI, 2.1-2.6]), while Hispanic individuals had an advantage over black individuals in the calculated plasma reactive antibody group of 90% or higher (HR, 2.5 [95% CI, 2.1-2.8]). Once on the inactive list, white individuals were more likely than Hispanic individuals (HR, 1.2 [95% CI, 1.17-1.3]) or black individuals (HR, 1.4 [95% CI, 1.3-1.4]) to resolve issues for inactivity resulting in activation. Conclusions and Relevance: For patients who are highly sensitized, there continues to be less access to kidney transplant in the black population after the implementation of the Kidney Allocation System. Health disparities continue after listing where individuals from minority groups have greater difficulty in resolving issues of inactivity.
Importance: Inactive patients on the kidney transplant wait-list have a higher mortality. The implications of this status change on transplant outcomes between racial/ethnic groups are unknown. Objectives: To determine if activity status changes differ among races/ethnicities and levels of sensitization, and if these differences are associated with transplant probability after implementation of the Kidney Allocation System. Design, Setting, and Participants: A multistate model was constructed from the Organ Procurement and Transplantation Network kidney transplant database (December 4, 2014, to September 8, 2016). The time interval followed Kidney Allocation System implementation and provided at least 1-year follow-up for all patients. The model calculated probabilities between active and inactive status and the following competing risk outcomes: living donor transplant, deceased donor transplant, and death/other. This retrospective cohort study included 42 558 patients on the Organ Procurement and Transplantation Network kidney transplant wait-list following Kidney Allocation System implementation. To rule out time-varying confounding from relisting, analysis was limited to first-time registrants. Owing to variations in listing practices, primary center listing data were used for dually listed patients. Individuals listed for another organ or pancreatic islets were excluded. Analysis began July 2017. Main Outcome and Measures: Probabilities were determined for transitions between active and inactive status and the following outcome states: active to living donor transplant, active to deceased donor transplant, active to death/other, inactive to living donor transplant, inactive to deceased donor transplant, and inactive to death/other. Results: The median (interquartile range) age at listing was 55.0 (18.0-89.0) years, and 26 535 of 42 558 (62.4%) were men. White individuals were 43.3% (n = 18 417) of wait-listed patients, while black and Hispanic individuals made up 27.8% (n = 11 837) and 19.5% (n = 8296), respectively. Patients in the calculated plasma reactive antibody categories of 0% or 1% to 79% showed no statistically significant difference in transplant probability among races/ethnicities. White individuals had an advantage in transplant probability over black individuals in calculated plasma reactive antibody categories of 80% to 89% (hazard ratio [HR], 1.8 [95% CI, 1.4-2.2]) and 90% or higher (HR, 2.4 [95% CI, 2.1-2.6]), while Hispanic individuals had an advantage over black individuals in the calculated plasma reactive antibody group of 90% or higher (HR, 2.5 [95% CI, 2.1-2.8]). Once on the inactive list, white individuals were more likely than Hispanic individuals (HR, 1.2 [95% CI, 1.17-1.3]) or black individuals (HR, 1.4 [95% CI, 1.3-1.4]) to resolve issues for inactivity resulting in activation. Conclusions and Relevance: For patients who are highly sensitized, there continues to be less access to kidney transplant in the black population after the implementation of the Kidney Allocation System. Health disparities continue after listing where individuals from minority groups have greater difficulty in resolving issues of inactivity.
Authors: John J Friedewald; Ciara J Samana; Bertram L Kasiske; Ajay K Israni; Darren Stewart; Wida Cherikh; Richard N Formica Journal: Surg Clin North Am Date: 2013-12 Impact factor: 2.741
Authors: R E Patzer; J P Perryman; J D Schrager; S Pastan; S Amaral; J A Gazmararian; M Klein; N Kutner; W M McClellan Journal: Am J Transplant Date: 2012-01-10 Impact factor: 8.086
Authors: David A Axelrod; Nino Dzebisashvili; Mark A Schnitzler; Paolo R Salvalaggio; Dorry L Segev; Sommer E Gentry; Janet Tuttle-Newhall; Krista L Lentine Journal: Clin J Am Soc Nephrol Date: 2010-08-26 Impact factor: 8.237
Authors: Rachel E Patzer; Laura C Plantinga; Sudeshna Paul; Jennifer Gander; Jenna Krisher; Leighann Sauls; Eric M Gibney; Laura Mulloy; Stephen O Pastan Journal: JAMA Date: 2015-08-11 Impact factor: 56.272
Authors: Allan B Massie; Xun Luo; Bonnie E Lonze; Niraj M Desai; Adam W Bingaman; Matthew Cooper; Dorry L Segev Journal: J Am Soc Nephrol Date: 2015-12-17 Impact factor: 10.121
Authors: Sanjay Kulkarni; Isaac Hall; Richard Formica; Carrie Thiessen; Darren Stewart; Geliang Gan; Erich Greene; Yanhong Deng Journal: PLoS One Date: 2017-12-29 Impact factor: 3.240
Authors: Silvi Shah; Annette L Christianson; Karthikeyan Meganathan; Anthony C Leonard; Daniel P Schauer; Charuhas V Thakar Journal: J Am Soc Nephrol Date: 2019-09-25 Impact factor: 10.121
Authors: Jill Krissberg; Matthew Kaufmann; Anshal Gupta; Eran Bendavid; Margaret Stedman; Xingxing Cheng; Jane Tan; Paul Grimm; Abanti Chaudhuri Journal: Clin J Am Soc Nephrol Date: 2021-10-20 Impact factor: 8.237
Authors: Prakriti Shrestha; Sarah E Van Pilsum Rasmussen; Elizabeth A King; Elisa J Gordon; Ruth R Faden; Dorry L Segev; Casey Jo Humbyrd; Mara McAdams-DeMarco Journal: BMC Geriatr Date: 2022-07-08 Impact factor: 4.070
Authors: Maureen R Benjamins; Peter Lorenz; Nazia S Saiyed; Abigail Silva; Holly J Mattix-Kramer; Paulina Pys; Andrew Schulz Journal: J Gen Intern Med Date: 2022-03-09 Impact factor: 6.473
Authors: Richelle N DeBlasio; Larissa Myaskovsky; Andrea F DiMartini; Emilee Croswell; Donna M Posluszny; Chethan Puttarajappa; Galen E Switzer; Ron Shapiro; Annette J DeVito Dabbs; Amit D Tevar; Sundaram Hariharan; Mary Amanda Dew Journal: Transplantation Date: 2022-04-01 Impact factor: 5.385
Authors: Rachel B Atkinson; Gezzer Ortega; Alexander R Green; Maria B J Chun; David T Harrington; Pamela A Lipsett; John T Mullen; Emil Petrusa; Emma Reidy; Adil H Haider; Douglas S Smink Journal: J Surg Educ Date: 2020-07-30 Impact factor: 2.891
Authors: Hannah Wesselman; Christopher Graham Ford; Yuridia Leyva; Xingyuan Li; Chung-Chou H Chang; Mary Amanda Dew; Kellee Kendall; Emilee Croswell; John R Pleis; Yue Harn Ng; Mark L Unruh; Ron Shapiro; Larissa Myaskovsky Journal: Clin J Am Soc Nephrol Date: 2021-01-28 Impact factor: 8.237
Authors: Salman Ahmed; Cameron T Nutt; Nwamaka D Eneanya; Peter P Reese; Karthik Sivashanker; Michelle Morse; Thomas Sequist; Mallika L Mendu Journal: J Gen Intern Med Date: 2020-10-15 Impact factor: 5.128